|
April 28, 2021
|
Histogen to Report Second Quarter 2021 Financial Results and Provide Business Update
|
|
|
March 30, 2021
|
Histogen to Present at the 20th Annual Needham Virtual Healthcare Conference
|
|
|
March 25, 2021
|
Histogen Appoints Rochelle Fuhrmann to Board of Directors
|
|
|
March 16, 2021
|
Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients
|
|
|
March 15, 2021
|
Histogen Announces Removal of Clinical Hold by FDA for HST-003 IND to Initiate a Phase 1/2 Trial for Knee Cartilage Regeneration
|
|
|
March 11, 2021
|
Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update
|
|
|
March 10, 2021
|
Histogen Strengthens Board of Directors with Appointment of Industry Leader Susan Windham-Bannister, Ph.D.
|
|
|
March 4, 2021
|
Histogen to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Business Update
|
|
|
March 2, 2021
|
Histogen to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
|
|
|
February 16, 2021
|
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
|
|
